이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Henry Schein 관리

관리 기준 확인 2/4

Henry Schein's CEO는 Stan Bergman, Jan1989 에 임명되었습니다 의 임기는 35.58 년입니다. 총 연간 보상은 $ 10.01M, 16.2% 로 구성됩니다. 16.2% 급여 및 83.8% 보너스(회사 주식 및 옵션 포함). 는 $ 52.65M 가치에 해당하는 회사 주식의 0.6% 직접 소유합니다. 52.65M. 경영진과 이사회의 평균 재임 기간은 각각 11 년과 12 년입니다.

주요 정보

Stan Bergman

최고 경영자

US$10.0m

총 보상

CEO 급여 비율	16.2%
CEO 임기	35.7yrs
CEO 소유권	0.6%
경영진 평균 재임 기간	11.1yrs
이사회 평균 재임 기간	12.1yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Stan Bergman 의 보수는 Henry Schein 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Jun 29 2024	n/a	n/a	US$352m
Mar 30 2024	n/a	n/a	US$388m
Dec 30 2023	US$10m	US$2m	US$416m
Sep 30 2023	n/a	n/a	US$445m
Jul 01 2023	n/a	n/a	US$458m
Apr 01 2023	n/a	n/a	US$478m
Dec 31 2022	US$8m	US$2m	US$538m
Sep 24 2022	n/a	n/a	US$638m
Jun 25 2022	n/a	n/a	US$650m
Mar 26 2022	n/a	n/a	US$646m
Dec 25 2021	US$11m	US$2m	US$631m
Sep 25 2021	n/a	n/a	US$626m
Jun 26 2021	n/a	n/a	US$606m
Mar 27 2021	n/a	n/a	US$438m
Dec 26 2020	US$6m	US$751k	US$403m
Sep 26 2020	n/a	n/a	US$591m
Jun 27 2020	n/a	n/a	US$585m
Mar 28 2020	n/a	n/a	US$713m
Dec 28 2019	US$14m	US$1m	US$701m
Sep 28 2019	n/a	n/a	US$488m
Jun 29 2019	n/a	n/a	US$444m
Mar 30 2019	n/a	n/a	US$438m
Dec 29 2018	n/a	n/a	US$431m
Sep 29 2018	n/a	n/a	US$304m
Jun 30 2018	n/a	n/a	US$352m
Mar 31 2018	n/a	n/a	US$377m

보상 대 시장: Stan 의 총 보상 ($USD 10.01M )은 UK 시장( $USD 3.41M ).

보상과 수익: Stan 의 보상은 작년에 20% 이상 증가한 반면 회사 수익은 20% 이상 감소했습니다.

CEO

Stan Bergman (74 yo)

35.7yrs

테뉴어

US$10,005,729

보상

Mr. Stanley M. Bergman, also known as Stan, has been the Chief Executive Officer and Executive Chairman of Henry Schein, Inc. since 1989 and has been its Executive Director since 1982. Mr. Bergman served a...

리더십 팀

이름	위치	테뉴어	보상	소유권
Stanley Bergman	Executive Chairman & CEO	35.7yrs	US$10.01m	0.59% $ 55.1m
James Breslawski	President	19.3yrs	US$2.69m	0.11% $ 10.5m
Ronald South	Senior VP & CFO	2.4yrs	US$2.35m	0.0078% $ 728.3k
Michael Ettinger	Executive VP & COO	2.2yrs	US$2.97m	0.080% $ 7.4m
Mark Mlotek	Executive VP	12.7yrs	US$3.22m	0.074% $ 6.9m
Olga Timoshkina	VP of Corporate Finance	3yrs	데이터 없음	데이터 없음
Christopher Pendergast	Senior VP & CTO	6.4yrs	데이터 없음	데이터 없음
Graham Stanley	VP of Investor Relations & Strategic Finance Project Officer	no data	데이터 없음	데이터 없음
Walter Siegel	Senior VP & Chief Legal Officer	10.9yrs	데이터 없음	0.031% $ 2.9m
Ann Gothard	Vice President of Global Corporate Media Relations	no data	데이터 없음	데이터 없음
Lorelei McGlynn	Senior VP & Chief Human Resources Officer	11.3yrs	데이터 없음	0.057% $ 5.3m
Gerard Meuchner	Chief Global Communications Officer & VP	12.6yrs	데이터 없음	데이터 없음

11.1yrs

평균 재임 기간

63yo

평균 연령

경험이 풍부한 관리: 0L3C 의 관리팀은 노련하고 경험 (평균 재직 기간 11 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Stanley Bergman	Executive Chairman & CEO	42.7yrs	US$10.01m	0.59% $ 55.1m
Mark Mlotek	Executive VP	29yrs	US$3.22m	0.074% $ 6.9m
Philip Laskawy	Independent Lead Director	22.6yrs	US$335.40k	0.029% $ 2.7m
Joseph Herring	Independent Director	8.3yrs	US$313.00k	0.018% $ 1.6m
Louis Sullivan	Chairman of Medical Advisory Board	18.2yrs	US$267.40k	데이터 없음
Norman Matthews	Member of Medical Advisory Board	no data	US$265.15k	데이터 없음
Bradley Sheares	Independent Director	14.7yrs	US$304.20k	0.0026% $ 244.0k
Carol Raphael	Independent Director	12.1yrs	US$282.60k	0.023% $ 2.1m
Kurt Kuehn	Independent Director	8.3yrs	US$316.40k	0.0014% $ 129.0k
Deborah Derby	Independent Director	3.6yrs	US$304.80k	0.00060% $ 55.7k
Mohamad Ali	Independent Director	3.6yrs	US$271.60k	0.0060% $ 558.5k
Anne Margulies	Independent Director	6.3yrs	US$291.40k	0.015% $ 1.4m

12.1yrs

평균 재임 기간

69yo

평균 연령

경험이 풍부한 이사회: 0L3C 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 12 년).

Henry Schein 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Insider recently sold US$1.5m worth of stock

Henry Schein, Inc. Announces Appointment of Members to the Company’S Executive Management Committee

Henry Schein, Inc., Annual General Meeting, May 21, 2024

Insider recently sold US$478k worth of stock

Henry Schein Appoints Carole T. Faig as New Independent Director

Insider recently sold US$835k worth of stock

Recent updates

Henry Schein, Inc.(NasdaqGS:HSIC) dropped from FTSE All-World Index (USD)

Insider recently sold US$1.5m worth of stock

Second quarter 2024 earnings released: EPS: US$0.81 (vs US$1.07 in 2Q 2023)

Henry Schein, Inc. Revises Earnings Guidance for the Year 2024

Henry Schein, Inc. to Report Q2, 2024 Results on Aug 06, 2024

Henry Schein, Inc. Revises Earnings Guidance for the Year 2024

First quarter 2024 earnings released: EPS: US$0.72 (vs US$0.92 in 1Q 2023)

Henry Schein, Inc. to Report Q1, 2024 Results on May 07, 2024

Henry Schein, Inc. Announces Appointment of Members to the Company’S Executive Management Committee

Henry Schein, Inc. (NasdaqGS:HSIC) completed the acquisition of an unknown majority interest in TriMed, Inc.

Henry Schein, Inc., Annual General Meeting, May 21, 2024

Insider recently sold US$478k worth of stock

Full year 2023 earnings released: EPS: US$3.19 (vs US$3.95 in FY 2022)

Henry Schein, Inc. Presents Comprehensive Lineup of Solutions At the 2024 Chicago Dental Society Mid Winter Meeting

Henry Schein, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Henry Schein, Inc. (NasdaqGS:HSIC) signed an agreement to acquire an unknown majority interest in TriMed, Inc.

Henry Schein Appoints Carole T. Faig as New Independent Director

Henry Schein Announces Receipt of Deficiency Notice From Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

Henry Schein, Inc. Provides Earnings Guidance for 2023

Henry Schein, Inc. announced delayed 10-Q filing

Henry Schein, Inc. (NasdaqGS:HSIC) completed the acquisition of an unknown majority stake in Shield HealthCare, Inc.

Henry Schein, Inc. Affirms Earnings Guidance for the Full Year of 2023

New minor risk - Earnings quality

Second quarter 2023 earnings released: EPS: US$1.07 (vs US$1.17 in 2Q 2022)

Henry Schein, Inc. (NasdaqGS:HSIC) signed an agreement to acquire a majority stake in Shield HealthCare, Inc.

Henry Schein, Inc. (NasdaqGS:HSIC) acquired a majority stake in Large Practice Sales LLC.

Henry Schein, Inc. to Report Q2, 2023 Results on Aug 07, 2023

Insider recently sold US$835k worth of stock

Executive VP recently sold US$1.9m worth of stock

Henry Schein, Inc. Provides Sales Guidance for the Fiscal Year 2023

First quarter 2023 earnings released: EPS: US$0.92 (vs US$1.32 in 1Q 2022)

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Regional Healthcare Group Pty Ltd.

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Regional Healthcare Group Pty Ltd.

Henry Schein, Inc. (NasdaqGS:HSIC) agreed to acquire SIN - Sistema de Implante Nacional S.A. from Southern Cross Group.

Independent Director recently sold US$148k worth of stock

Independent Lead Director recently sold US$504k worth of stock

Now 20% undervalued after recent price drop

Independent Director recently sold US$923k worth of stock

Full year 2022 earnings released: EPS: US$3.95 (vs US$4.51 in FY 2021)

Henry Schein, Inc. Reports Impairment Charge on Intangible Assets for the Fourth Quarter Ended December 31, 2022

Henry Schein, Inc. (NasdaqGS:HSIC) announces an Equity Buyback for $400 million worth of its shares.

Henry Schein, Inc. to Report Q4, 2022 Results on Feb 16, 2023

Insider recently sold US$1.2m worth of stock

Henry Schein, Inc. to Report Q3, 2022 Results on Nov 01, 2022

Henry Schein, Inc. Announces its Lineup of Products and Solutions At the American Association of Oral and Maxillofacial Surgeons (AAOMS) Annual Conference in New Orleans, La. from September 12 Through September 17

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Midway Dental Supply, Inc.

Henry Schein, Inc. Announces the Passing of Board Member E. Dianne Rekow

Second quarter 2022 earnings released: EPS: US$1.17 (vs US$1.11 in 2Q 2021)

Henry Schein, Inc. Affirms Earnings Guidance for the Full Year 2022

Henry Schein, Inc. Appoints Mark Hillebrandt as Chief Digital Revenue Officer

Henry Schein, Inc. to Report Q2, 2022 Results on Aug 02, 2022

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Condor Dental Research Company SA from MCCB Holding Sarl.

Henry Schein, Inc.(NasdaqGS:HSIC) dropped from Russell 1000 Dynamic Index

Henry Schein, Inc. (NasdaqGS:HSIC) entered into a definitive agreement to acquire Condor Dental Research Company SA from MCCB Holding Sarl.

Insider recently sold US$982k worth of stock

Henry Schein, Inc. Appoints Dirk Benson as Chief Commercial Officer of North America Distribution Group

Henry Schein, Inc. Provides Earnings Guidance for the Year 2022

First quarter 2022 earnings released: EPS: US$1.32 (vs US$1.17 in 1Q 2021)

Henry Schein, Inc. to Report Q1, 2022 Results on May 03, 2022

Henry Schein Inc. Announces Executive Changes, Effective from July 1, 2022

Henry Schein Promotes Jennifer Ferrero to Corporate Secretary, Effective July 1, 2022

Executive VP recently sold US$2.0m worth of stock

Henry Schein to Showcase A Wide Portfolio of Products, Services, and Solutions During the Chicago Midwinter Dental Meeting

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Henry Schein, Inc. Provides Earnings Guidance for the Year 2022

Henry Schein, Inc. Announces Lineup of New Products and Solutions At the Greater New York Dental Meeting

Third quarter 2021 earnings released: EPS US$1.16 (vs US$1.00 in 3Q 2020)

Henry Schein, Inc. Announces Not to Provide Guidance for the Year 2021

Second quarter 2021 earnings released: EPS US$1.11 (vs US$0.08 loss in 2Q 2020)